BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 31428892)

  • 21. Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing Escherichia coli.
    Jo KJ; Yoo S; Song JY; Kim SH; Park SE
    Pediatr Neonatol; 2021 May; 62(3):271-277. PubMed ID: 33602619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Seo YB; Lee J; Kim YK; Lee SS; Lee JA; Kim HY; Uh Y; Kim HS; Song W
    BMC Infect Dis; 2017 Jun; 17(1):404. PubMed ID: 28592240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study.
    Castillo-Tokumori F; Irey-Salgado C; Málaga G
    Int J Infect Dis; 2017 Feb; 55():16-19. PubMed ID: 27979787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt.
    Hassuna NA; Khairalla AS; Farahat EM; Hammad AM; Abdel-Fattah M
    Sci Rep; 2020 Feb; 10(1):2772. PubMed ID: 32066805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
    Cheng MF; Chen WL; Hung WY; Huang IF; Chiou YH; Chen YS; Lee SS; Hung CH; Wang JL
    Pediatr Infect Dis J; 2015 May; 34(5):469-75. PubMed ID: 25879646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-Acquired Uropathogenic
    Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
    MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia.
    Hammami S; Saidani M; Ferjeni S; Aissa I; Slim A; Boutiba-Ben Boubaker I
    Microb Drug Resist; 2013 Jun; 19(3):231-6. PubMed ID: 23363379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S; Weber R; Zbinden R; Ruef C; Hasse B
    Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
    Blanco VM; Maya JJ; Correa A; Perenguez M; Muñoz JS; Motoa G; Pallares CJ; Rosso F; Matta L; Celis Y; Garzon M; Villegas MV
    Enferm Infecc Microbiol Clin; 2016 Nov; 34(9):559-565. PubMed ID: 26774256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil.
    Gonçalves LF; de Oliveira Martins-Júnior P; de Melo ABF; da Silva RCRM; de Paulo Martins V; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2016 Sep; 6():1-4. PubMed ID: 27530830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008.
    Qi C; Pilla V; Yu JH; Reed K
    Diagn Microbiol Infect Dis; 2010 May; 67(1):87-91. PubMed ID: 20227224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of Extended-Spectrum β-Lactamase-Producing Pathogens in Community-Acquired Urinary Tract Infections Among Infants at a Pediatric Emergency Department.
    Tamas V; Shah S; Hollenbach KA; Kanegaye JT
    Pediatr Emerg Care; 2022 Mar; 38(3):e1053-e1057. PubMed ID: 35226630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
    Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors of urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children: a prospective Tunisian study.
    Boussetta A; Kharbach N; Abdellatif A; Karray A; Jellouli M; Gargah T
    Tunis Med; 2023 Feb; 101(2):285-291. PubMed ID: 37682274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.